Comparative study of dobutamine stress echocardiography and dual single-photon emission computed tomography (Thallium-201 and I-123 BMIPP) for assessing myocardial viability after acute myocardial infarction

Circulation Journal

Volumn 66, Issue 12, 2002, Pages 1132-1138

  Yasugi, Naoko ^a   Koyanagi, Samon ^b   Ohzono, Keizaburo ^c   Sakai, Kikuo ^c   Matsumoto, Takahiro ^c   Sako, Shigeki ^c   Homma, Tomoki ^c   Azakami, Shirou ^c   Hiroki, Tadayuki ^a  

^a Fukuoka University Chikushi Hospital   (Japan)

^b FUKUOKA HIGASHI MEDICAL CENTER   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

Author keywords

Acute myocardial infarction; Dobutamine stress echocardiography; Myocardial viability; SPECT

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; DOBUTAMINE; THALLIUM CHLORIDE TL 201; DIAGNOSTIC AGENT; FATTY ACID; IODOBENZENE; IODOFILTIC ACID; RADIOACTIVE IODINE; THALLIUM;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FUNCTIONAL ASSESSMENT; HEART INFARCTION SIZE; HEART LEFT VENTRICLE WALL MOTION; HUMAN; MALE; PREDICTION; RESTENOSIS; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL SIGNIFICANCE; STRESS ECHOCARDIOGRAPHY; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING ORGAN SYSTEMS; CONVALESCENCE; HEART; HEART INFARCTION; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; DOBUTAMINE; ECHOCARDIOGRAPHY, STRESS; FATTY ACIDS; FEMALE; HEART; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECOVERY OF FUNCTION; THALLIUM RADIOISOTOPES; TISSUE SURVIVAL; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0036895638     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.66.1132     Document Type: Article

References (31)

1. Bonow R. Identification of viable myocardium. Circulation 1996; 94: 2674-2680.
2. Dilsizian V. Myocardial viability: Contractile reserve or cell membrane integrity? J Am Coll Cardiol 1996; 28: 443-446.
3. Pierald LA, Landsheere CM, Berthe C, Rigo P, Kulbertus HE. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: Comparison with positron emission tomography. J Am Coll Cardiol 1990; 15: 1021-1031.
4. Smart SC, Sawada S, Ryan T, Segar D, Atherton L, Berkovitz K, et al. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993; 88: 405-415.
5. Kaul S. Response of dysfunctional myocardium to dobutamine: 'The eyes see what the mind knows!' J Am Coll Cardiol 1996; 27: 1608- 1611.
6. La Canna G, Alfierri O, Giubbini R, Gargano M, Roberto F, Visioli O, et al. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 1994; 23: 617-626.
7. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echo-cardiography in myocardial hibernation: Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995; 91: 663-670.
8. Senior R, Lahiri A. Enhanced detection of myocardial ischemia by stress dobutamine echocardiography utilizing the 'biphasic' response of wall thickening during low and high dose dobutamine infusion. J Am Coll Cardiol 1995; 26: 26-32.
9. Arnese M, Cornel JH, Salustri A, Maat APWM, Elhendy A, Reijs AEM, et al. Prediction of improvement of regional left ventricular function after surgical revascularization: A comparison of low-dose dobutamine echocardiography with 201-Tl SPECT. Circulation 1995; 91: 2748-2752.
10. Perrone-Filardi P, Pace L, Prastaro M, Fiorenzo S, Betocchi S, Soricelli A, et al. Assessment of myocardial viability in patients with chronic coronary artery disease: Rest-4hour-24hour 201-Tl tomography versus dobutamine echocardiography. Circulation. 1996; 94: 2712-2719.
11. Bax JJ, Cornel JH, Visser FC, Fioretti PM, Lingen A, Reijs AE, et al. Prediction of recovery of myocardial dysfunction after revascularization. J Am Coll Cardiol 1996; 28: 558-564.
12. Claeys MJ, Rademakers FE, Vrints CJ, Krug B, Bosmans JM, Conraads V, et al. Comparative study of rest technetium-99m sestamibi SPET and low-dose dobutamine stress echocardiography for the early assessment of myocardial viability after acute myocardial infarction: Importance of the severity of the infarct-related stenosis. Eur J Nucl Med 1996; 23: 748-755.
13. Qureshi U, Nagueh SF, Afridi I, Vaduganathan P, Blaustein A, Verani MS, et al. Dobutamine echocardiography and Quantitative rest-redistribution 201-Tl tomography in myocardial hibernation. Circulation. 1997; 95: 626-635.
14. Vanoverschelde JL, D'hondt AM, Marwick T, Bernhard LG, Kock MD, Dion R, et al. Head to head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol 1996; 28: 432-442.
15. Wiggers H, Nielsen TT, Bottcher M, Egeblad H, Botter HE. Positron emission tomography and low-dose dobutamine echocardiography in the prediction of postrevascularization improvement in left ventricular function and exercise parameters. Am Heart J 2000; 140: 928-936.
16. Tani T, Teragaki M, Watanabe H, Muro T, Yamagishi H, Akioka K, et al. Prediction of functional recovery in patients with myocardial infarction after revascularization. Jpn Circ J 2001; 65: 177-181.
17. Senior R, Lahiri A. Value of dobutamine echocardiography for the assessment of myocardial viability for revascularization. Congest Heart Fail 2001; 7: 30-36.
18. Singh BK, Chaudhry FA. Echocardiographic assessment of viable myocardium. Prog Cardiovasc Dis 2001; 43: 351-361.
19. Tamaki N, Kawamoto M, Yonekura Y, Fujibayashi Y, Takahashi N, Konishi J, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: Assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Med 1992; 33: 659-667.
20. Nakata T, Hashimoto A, Eguchi M. Cardiac BMIPP imaging in acute myocardial infarction. Int J Card Imaging 1999; 15: 21-26.
21. Kawai Y, Tsukamoto E, Nozaki Y, Morita K, Sakurai M, Tamaki N. Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain. J Am Coll Cardiol 2001; 38: 1888-1894.
22. Hambye AS, Vaerenberg MM, Dobbeleir AA, Heuvel PA, Franken PR. Abnormal BMIPP uptake in chronically dysfunctional myocardial segments: Correlation with contractile response to low-dose dobutamine. J Nucl Med 1998; 39: 1845-1850.
23. Franken PR, Dendale P, Geeter FD, Demoor D, Block P, Bossuyt A. Prediction of functional outcome after myocardial infarction using BMIPP and sestamibi scintigraphy. J Nucl Med 1996; 37: 718-722.
24. Shiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigebaum H, et al. Recommendation for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989; 2: 358-367.
25. Dilsizian V, Rocco TP, Freedman NM, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the rejection of thallium after stress-redistribution imaging. N Engl J Med 1990; 323: 141-146.
26. Koyanagi S, Eastham CL, Harrison DG, Marcus ML. Transmural validation in the relationship between myocardial infarct size and risk area. Am J Physiol 1982; 242(Heart Circ Physiol 11): H867-H874.
27. Kloner RA. Does reperfusion injury exist in humans? J Am Coll Cardiol 1993; 21: 531-545.
28. Nanto S, Masuyama T, Lim YJ, Hori M, Kodama K, Kamada T. Demonstration of functional border zone with myocardial contrast echocardiography in human hearts. Circulation. 1993; 88: 447-453.
29. Finkelhor RS, Pajouh M, Kett A, Srefanski R, Bosich G, Youssefi ME, et al. Clinical impact of second harmonic imaging and left heart contrast in echocardiographic stress testing. Am J Cardiol 2000; 85: 740-743.
30. Mertes H, Sawada SG, Ryan T, Segar DS, Kovacs R, Foltz J, et al. Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography: Experience in 1118 patients. Circulation 1993; 88: 15-19.
31. Secknus MA, Marwick TH. Evolution of dobutamine echocardiogarphy protocols and indications: Safety and side effects in 3,011 studies over 5 years. J Am Coll Cardiol 1997; 29: 1234-1240.